VIB VZW
223Patents
217Active
223Granted
60Portfolio score
Filing activity: Sep 25, 2003 → May 14, 2024 · 40 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10400014B2 | Mutant CsgG pores | Chemistry; Metallurgy | 33 | Active |
| US8026083B2 | Yarrowia lipolytica and Pichia pastoris HAC1 nucleic acids | Emerging Cross-Sectional Technologies | 20 | Active |
| US7507573B2 | Modification of protein glycosylation in methylotrophic yeast | Chemistry; Metallurgy | 19 | Expired |
| US11034734B2 | Mutant pores | Chemistry; Metallurgy | 19 | Active |
| US10640542B2 | Fusokines involving cytokines with strongly reduced receptor binding affinities | Chemistry; Metallurgy | 17 | Active |
| US9732135B2 | Targeting of human interferon antagonists | Chemistry; Metallurgy | 16 | Active |
| US9408885B2 | Combinations of therapeutic agents for treating melanoma | Physics | 15 | Active |
| US9486541B2 | Detecting and treating dementia | Chemistry; Metallurgy | 15 | Active |
| US7244619B2 | Serum marker for measuring liver fibrosis | Emerging Cross-Sectional Technologies | 14 | Expired |
| US9492562B2 | Targeted human-interferon fusion proteins | Chemistry; Metallurgy | 14 | Active |
| US8597906B2 | Glycosylation of molecules | Emerging Cross-Sectional Technologies | 14 | Active |
| US8058053B2 | Modification of protein glycosylation in methylotrophic yeast | Chemistry; Metallurgy | 14 | Active |
| US9878014B2 | Targeted human-interferon fusion proteins | Chemistry; Metallurgy | 14 | Active |
| US10072059B2 | Targeting of human interferon antagonists | Chemistry; Metallurgy | 13 | Active |
| US11572387B2 | Protein pores | Chemistry; Metallurgy | 13 | Active |
| US10034919B2 | Targeted human-interferon fusion proteins | Chemistry; Metallurgy | 13 | Active |
| US9932409B2 | Targeted modified IL-1 family members | Chemistry; Metallurgy | 13 | Active |
| US9914759B2 | Targeted modified TNF family members | Chemistry; Metallurgy | 13 | Active |
| US8815580B2 | Cells producing glycoproteins having altered glycosylation patterns and method and use thereof | Chemistry; Metallurgy | 13 | Active |
| US8663971B2 | Protein glycosylation modification in methylotrophic yeast | Emerging Cross-Sectional Technologies | 12 | Active |
| US7575878B2 | Methods of inhibiting leptin-induced signaling with fibronectin III domain antibodies | Chemistry; Metallurgy | 12 | Expired |
| US10407480B2 | Targeted modified TNF family members | Chemistry; Metallurgy | 12 | Active |
| US9617548B2 | Liver-specific nucleic acid regulatory elements and methods and use thereof | Chemistry; Metallurgy | 12 | Active |
| US8354268B2 | Protein glycosylation modification in methylotrophic yeast | Emerging Cross-Sectional Technologies | 12 | Expired |
| US10035835B2 | Targeted modified TNF family members | Chemistry; Metallurgy | 12 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.